Brands and Their Owners
Patent Number: 9387211
Patent Date: 2016-07-12
Patent type: utility
The invention relates to methods and kits for the treatment of, prevention of, and lowering the chances of developing Cushing's Disease and/or hypercortisolism by the administration of a tyrosine kinase inhibitor, such as gefitinib.
Inventors
First Name | Last Name | City | State | Country |
---|---|---|---|---|
Shlomo | Melmed | - | - | - |
Hidenori | Fukuoka | - | - | - |
IPCs
Section | Class | Sub Class | Group | Sub Group |
---|---|---|---|---|
A | 61 | K | 31 | 5377 |
A | 61 | P | 5 | 38 |
A | 61 | K | 31 | 713 |
A | 61 | K | 48 | 00 |
A | 61 | K | 31 | 535 |
C | 12 | Q | 1 | 48 |
G | 01 | N | 33 | 74 |
Assignee
Organization | First Name | Last Name | City | State | Country |
---|---|---|---|---|---|
Cedars-Sinai Medical Center | - | - | - | - | - |